18th World Conference on Lung Cancer (WCLC) 2017, PR 01.04 - Nursing Immunotherapy Guidelines, Presenting Author(s): Kimberly Ann Rohan, Anne Fraser.
Omalizumab vermindert jeuk gerelateerd aan checkpointremmers en anti-HER2-therapieën
jun 2021 | Borstkanker, Immuuntherapie, Longoncologie, Uro-oncologie